Most lately, it has been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in equivalent regions as classical opioid receptors, it binds to some wide array of endogenous opioids. As opposed to most opioid receptors, this receptor functions being a scavenger and will not